GeoPolitics Pulse

The Heartbeat of World events

European Commission Approves Astellas’ PADCEV TM (enfortumab vedotin) in …

by ·

European Commission Approves Astellas’ PADCEVTM (enfortumab vedotin) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of …Read More

Related posts:

  1. European Commission Approves Astellas’ PADCEV™ (enfortumab vedotin) in Combination …
  2. Enfortumab vedotin plus pembrolizumab approved in Japan for urothelial carcinoma
  3. European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Padcev …
  4. Astellas Receives Positive CHMP Opinion for Zolbetuximab in Combination with …
  5. Astellas unveils new Japan site for cell therapy research arm – Fierce Biotech